The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1455
ISSUE1455
November 10, 2014
Two New GLP-1 Receptor Agonists for Diabetes
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Two New GLP-1 Receptor Agonists for Diabetes
November 10, 2014 (Issue: 1455)
Two new injectable GLP-1 (glucagon-like peptide-1)
receptor agonists, dulaglutide (Trulicity [trū li si tee] –
Lilly) and albiglutide (Tanzeum [tan' zee um] – GSK),
have been approved by the FDA for once-weekly
treatment of type 2 diabetes....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.